VY BlackRock Health Sciences Opportunities Portfolio

Scorecard
2 / 5 Stars
Lipper
---
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
---
TheStreet.com
A+ (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 3.0 3.0
Stocks 76.33 76.33
Bonds 0.0 0.0
Other 6.93 6.93
Foreign Bonds 0.0 0.0
Foreign Stocks 13.74 13.74
Convertible 0.0 0.0
Preferred 0.0 0.0

Updated 03.31.2014

Top 10 Holdings

Performance as of 06.30.2014

Portfolio as of 03.31.2014

Ticker YTD Return % % Net Assets
Johnson & Johnson JNJ 17.08 3.99
Biogen Idec Inc BIIB 16.16 3.82
Pfizer Inc PFE -0.1 3.46
Merck & Co Inc MRK 18.66 3.19
AbbVie Inc ABBV 9.28 3.02
Alexion Pharmaceuticals Inc ALXN 22.51 2.58
Bayer AG BAYZF 3.07 2.55
Celgene Corp CELG 4.75 2.49
UnitedHealth Group Inc UNH 9.62 2.34
Covidien PLC COV 34.36 2.22